LABORATORY REPORT
Patient: Miguel Fernandez    DOB: 11/30/1975    MRN: 34567890
Collection Date: 2024-10-10 07:15 AM (Fasting)
Ordering Provider: Dr. Elena Rodriguez, MD
Performing Lab: Quest Diagnostics - Los Angeles

================================================================================
COMPREHENSIVE METABOLIC PANEL
================================================================================
Test Name                    Result      Reference Range     Flag
--------------------------------------------------------------------------------
Glucose, Fasting             138 mg/dL   70-100 mg/dL       HIGH
BUN                          16 mg/dL    7-20 mg/dL
Creatinine, Serum            1.0 mg/dL   0.7-1.3 mg/dL
eGFR                         >60 mL/min  >60 mL/min
Sodium                       140 mEq/L   136-145 mEq/L
Potassium                    4.2 mEq/L   3.5-5.0 mEq/L
Chloride                     102 mEq/L   98-106 mEq/L
CO2                          26 mEq/L    22-29 mEq/L
Calcium                      9.4 mg/dL   8.5-10.5 mg/dL

================================================================================
LIPID PANEL
================================================================================
Test Name                    Result      Reference Range     Flag
--------------------------------------------------------------------------------
Total Cholesterol            192 mg/dL   <200 mg/dL
LDL Cholesterol (calc)       106 mg/dL   <100 mg/dL         HIGH
HDL Cholesterol              41 mg/dL    >40 mg/dL
Triglycerides                225 mg/dL   <150 mg/dL         HIGH

================================================================================
HEMOGLOBIN A1C
================================================================================
Test Name                    Result      Reference Range     Flag
--------------------------------------------------------------------------------
Hemoglobin A1c               7.2%        <5.7%              HIGH

Interpretation: Improved glycemic control compared to prior (was 7.8%).
Now closer to goal of <7%.

================================================================================
THYROID
================================================================================
Test Name                    Result      Reference Range     Flag
--------------------------------------------------------------------------------
TSH                          2.4 mIU/L   0.45-4.5 mIU/L

================================================================================
LIVER FUNCTION
================================================================================
Test Name                    Result      Reference Range     Flag
--------------------------------------------------------------------------------
AST (SGOT)                   28 U/L      10-40 U/L
ALT (SGPT)                   38 U/L      7-56 U/L

================================================================================
URINE MICROALBUMIN
================================================================================
Test Name                    Result      Reference Range     Flag
--------------------------------------------------------------------------------
Microalbumin, Urine          42 mg/L     <30 mg/L           HIGH
Creatinine, Urine            95 mg/dL    20-275 mg/dL
Albumin/Creatinine Ratio     44 mg/g     <30 mg/g           HIGH

Interpretation: Moderately increased albuminuria (microalbuminuria, A2 stage).
This indicates early diabetic kidney disease. ACE inhibitor or ARB therapy
is indicated.

================================================================================
LABORATORY INTERPRETATION - SUMMARY
================================================================================
COMPARISON TO BASELINE (01/30/2024):

1. DIABETES CONTROL IMPROVING:
   - HbA1c: 7.4% -> 7.2% (good progress)
   - Fasting glucose: 186 -> 138 mg/dL (improved)
   - Patient making progress with medications and lifestyle changes

2. LIPIDS IMPROVED:
   - Total cholesterol: 234 -> 192 mg/dL
   - LDL: 148 -> 106 mg/dL (much improved but still slightly above goal)
   - HDL: 36 -> 41 mg/dL (improved to normal range)
   - Triglycerides: 250 -> 225 mg/dL (improved but still elevated)
   - Statin therapy is effective

3. MICROALBUMINURIA DETECTED:
   - ACR 44 mg/g indicates early diabetic nephropathy
   - Patient is on ACE inhibitor (lisinopril) which is appropriate
   - Will need ongoing monitoring; target is to reduce or stabilize

4. RENAL FUNCTION STABLE:
   - eGFR remains >60
   - Creatinine 1.0 (slight increase from 0.9 - monitor)

5. LIVER ENZYMES IMPROVED:
   - ALT normalized (was 48, now 38)
   - NAFLD may be improving with weight loss and diabetes control

OVERALL: Patient showing good response to treatment with improvement in
glycemic control, lipids, and liver enzymes. New finding of microalbuminuria
indicates need for continued renal protection strategies.

================================================================================
Report electronically signed by: Maria Santos, MD, Laboratory Director
10/10/2024 1:30 PM
================================================================================
